Progressivity analysis of pleomorphic adenoma toward carcinoma ex pleomorphic adenoma
this tumour can transform into a CXPA remains unclear. Purpose: The aim of this study was to analyse the possibility of pathogenesis and progressivity of PA to CXPA. Methods: Twenty-four samples of PA and three control samples of CXPA were stained with haematoxylin and eosin (HE), Mallory’s trichrome, and Periodic acid–Schiff (PAS). All of the PA cases were identified through different kinds of stroma, tumour cells types, morphologic patterns, or else through atypical appearance of the PA similar to the CXPA. Results: Twenty-four samples of PA demonstrated that the most dominant stroma was myxofibrous, and the dominant tumour cell type was plasmacytoid cells with a trabecular pattern. Additionally, in the pleomorphic histological picture of adenomas we found several patterns of malignant tumour behaviour, including pseudopodia, metaplasia and hyalinisation, and cholesterol crystals that are thought to come from fat cell necrosis derived from adipose metaplasia. Conclusions: PA displays several atypical characteristics that have the potential to develop into malignancies such as CXPA, due to capsular infiltration, necrosis, hyalinization and high mitotic activity of cells, but all these atypical characteristics that we observed still cannot be clearly classified as CXPA because they require other specific examinations.
Soni A. Duct Pseudopodia: A new finding in parotid pleomorphic. Ann Clin Otolaryngol. 2019; 4(1): 1036.
Fonseca FP, Carvalho M de V, de Almeida OP, Rangel ALCA, Takizawa MCH, Bueno AG, Vargas PA. Clinicopathologic analysis of 493 cases of salivary gland tumors in a Southern Brazilian population. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114(2): 230–9.
García JJ. Atlas of salivary gland pathology. Cham: Springer International Publishing; 2019. p. 153–60.
Farhat F, Asnir RA, Yudhistira A, Daulay ER, Sagala IP. An uncommon occurrence of pleomorphic adenoma in the submandibular salivary gland: A case report. Open access Maced J Med Sci. 2018; 6(6): 1101–3.
Mariano FV, Noronha ALF, Gondak RO, de A.M. Altemani AM, de Almeida OP, Kowalski LP. Carcinoma ex pleomorphic adenoma in a Brazilian population: clinico-pathological analysis of 38 cases. Int J Oral Maxillofac Surg. 2013; 42(6): 685–92.
Valstar MH, de Ridder M, van den Broek EC, Stuiver MM, van Dijk BAC, van Velthuysen MLF, Balm AJM, Smeele LE. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol. 2017; 66: 93–9.
Di Palma S. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. Head Neck Pathol. 2013; 7(Suppl 1): S68-76.
Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod Pathol. 1996; 9(6): 652–7.
Chiosea SI, Thompson LDR, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Cancer. 2016; 122(20): 3136–44.
Reisner E, Reisner H. Crowley’s An introduction to human disease: Pathology and pathophysiology correlations. 10th ed. Burlington: Jones & Bartlett Learning; 2017. p. 808.
Shah AAK, Mulla AF, Mayank M. Pathophysiology of myoepithelial cells in salivary glands. J Oral Maxillofac Pathol. 2016; 20(3): 480–90.
Koutlas IG, Dolan M, Lingen MW, Argyris PP. Plasmacytoid cells in salivary pleomorphic adenoma: an alternative interpretation of their immunohistochemical characteristics highlights function and capability for epithelial-mesenchymal transition. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 128(5): 515–29.
Nonitha S, Yogesh TL, Nandaprasad S, Maheshwari BU, Mahalakshmi IP, Veerabasavaiah BT. Histomorphological comparison of pleomorphic adenoma in major and minor salivary glands of oral cavity: A comparative study. J Oral Maxillofac Pathol. 2019; 23(3): 356–62.
Dulguerov P, Todic J, Pusztaszeri M, Alotaibi NH. Why do parotid pleomorphic adenomas recur? A systematic review of pathological and surgical variables. Front Surg. 2017; 4: 26.
Wyganowska-Świątkowska M, Tarnowski M, Murtagh D, Skrzypczak-Jankun E, Jankun J. Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review). Int J Mol Med. 2019; 43(1): 15–25.
Lopes MLD de S, Barroso KMA, Henriques ÁCG, Dos Santos JN, Martins MD, de Souza LB. Pleomorphic adenomas of the salivary glands: retrospective multicentric study of 130 cases with emphasis on histopathological features. Eur Arch Otorhinolaryngol. 2017; 274(1): 543–51.
Mahyudin F, Edward M, Basuki MH, Prawira KS. Analysis of immunity in osteosarcoma a basis for development following therapy. J Orthop Traumatol Surabaya. 2019; 7(2): 139–48.
Bhat V, Biniyam K, Aziz A, Yeshwanth S. Carcinoma ex-pleomorphic adenoma of submandibular salivary gland: A case report and review of literature. J Dr NTR Univ Heal Sci. 2017; 6(3): 185–8.
- Every manuscript submitted to must observe the policy and terms set by the Dental Journal (Majalah Kedokteran Gigi).
- Publication rights to manuscript content published by the Dental Journal (Majalah Kedokteran Gigi) is owned by the journal with the consent and approval of the author(s) concerned.
- Full texts of electronically published manuscripts can be accessed free of charge and used according to the license shown below.
- The Dental Journal (Majalah Kedokteran Gigi) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License